Advances in Multiple Sclerosis Research-Series I
Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Is...
I tiakina i:
| Hōputu: | Online |
|---|---|
| Reo: | Ingarihi |
| I whakaputaina: |
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Ngā marau: | |
| Urunga tuihono: | ONIX_20210501_9783039439478_329 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
| _version_ | 1869518312250015744 |
|---|---|
| collection | Directory of Open Access Books |
| description | Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials. |
| format | Online |
| id | doab-20.500.12854ir-68583 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-685832024-03-30T23:22:17Z Advances in Multiple Sclerosis Research-Series I Matsoukas, John Apostolopoulos, Vasso multiple sclerosis inflammation oxidative biomarker sample size autoimmune encephalitis plasma exchange autoimmunity immunotherapeutics clinical outcomes major depression bupropion S-adenosylmethionine vitamin D3 yoga craniopharyngioma fractionated stereotactic radiation treatments sphenoid sinusitis cranial nerve-VI palsy autoimmune diseases immune thrombocytopenic purpura alemtuzumab antibodies against GluR3 peptide cognitive impairment diagnosis neuropsychological assessment short intracortical inhibition intracortical facilitation fampridine walking disability TSPAN32 tetraspanins cellular immunity memory T cells tDCS neuroimaging positron emission tomography cerebral blood flow probiotics Streptococcus thermophilus ST285 MBP83–99 peptide mannan immune modulation agonist peptide gut microbiome gut–brain axis metagenomics disease-modifying treatments MS vaccine immunomodulation carriers B cell receptor delivery methods immunotherapy monoclonal antibodies T cell receptor tolerance diagnostic markers immunoglobulins kappa free light chains antigen-specific immunotherapies tolerogenic vaccines tolerance induction central nervous system myelin peptides myelin basic protei proteolipid protein myelin oligodendrocyte glycoprotein nanotechnology drug delivery nanosystems lipids polymers vaccines nanoparticles antigen-specific immunotherapy experimental autoimmune encephalomyelitis neurodegeneration chloroquine EAE dendritic cells microglia astrocytes oligodendrocytes conformational analysis peptides altered peptide ligands NMR spectroscopy NOE-constraints molecular dynamic trimolecular complex Multiple Sclerosis early-onset adult-onset Human Leucocyte Antigens immunogenetics clinical phenotype clinical outcome therapeutics antibody detection ELISA multivalency N-glucosylated peptide epitopes peptide conjugation MOG35-55 Graphite/SiO2 electrode voltammetry HPLC MS drugs thema EDItEUR::M Medicine and Nursing Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials. 2021-05-01T15:15:13Z 2021-05-01T15:15:13Z 2021 book ONIX_20210501_9783039439478_329 9783039439478 9783039439485 https://directory.doabooks.org/handle/20.500.12854/68583 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/3604 https://mdpi.com/books/pdfview/book/3604 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-03943-948-5 10.3390/books978-3-03943-948-5 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783039439478 9783039439485 334 Basel, Switzerland open access |
| spellingShingle | multiple sclerosis inflammation oxidative biomarker sample size autoimmune encephalitis plasma exchange autoimmunity immunotherapeutics clinical outcomes major depression bupropion S-adenosylmethionine vitamin D3 yoga craniopharyngioma fractionated stereotactic radiation treatments sphenoid sinusitis cranial nerve-VI palsy autoimmune diseases immune thrombocytopenic purpura alemtuzumab antibodies against GluR3 peptide cognitive impairment diagnosis neuropsychological assessment short intracortical inhibition intracortical facilitation fampridine walking disability TSPAN32 tetraspanins cellular immunity memory T cells tDCS neuroimaging positron emission tomography cerebral blood flow probiotics Streptococcus thermophilus ST285 MBP83–99 peptide mannan immune modulation agonist peptide gut microbiome gut–brain axis metagenomics disease-modifying treatments MS vaccine immunomodulation carriers B cell receptor delivery methods immunotherapy monoclonal antibodies T cell receptor tolerance diagnostic markers immunoglobulins kappa free light chains antigen-specific immunotherapies tolerogenic vaccines tolerance induction central nervous system myelin peptides myelin basic protei proteolipid protein myelin oligodendrocyte glycoprotein nanotechnology drug delivery nanosystems lipids polymers vaccines nanoparticles antigen-specific immunotherapy experimental autoimmune encephalomyelitis neurodegeneration chloroquine EAE dendritic cells microglia astrocytes oligodendrocytes conformational analysis peptides altered peptide ligands NMR spectroscopy NOE-constraints molecular dynamic trimolecular complex Multiple Sclerosis early-onset adult-onset Human Leucocyte Antigens immunogenetics clinical phenotype clinical outcome therapeutics antibody detection ELISA multivalency N-glucosylated peptide epitopes peptide conjugation MOG35-55 Graphite/SiO2 electrode voltammetry HPLC MS drugs thema EDItEUR::M Medicine and Nursing Advances in Multiple Sclerosis Research-Series I |
| title | Advances in Multiple Sclerosis Research-Series I |
| title_full | Advances in Multiple Sclerosis Research-Series I |
| title_fullStr | Advances in Multiple Sclerosis Research-Series I |
| title_full_unstemmed | Advances in Multiple Sclerosis Research-Series I |
| title_short | Advances in Multiple Sclerosis Research-Series I |
| title_sort | advances in multiple sclerosis research series i |
| topic | multiple sclerosis inflammation oxidative biomarker sample size autoimmune encephalitis plasma exchange autoimmunity immunotherapeutics clinical outcomes major depression bupropion S-adenosylmethionine vitamin D3 yoga craniopharyngioma fractionated stereotactic radiation treatments sphenoid sinusitis cranial nerve-VI palsy autoimmune diseases immune thrombocytopenic purpura alemtuzumab antibodies against GluR3 peptide cognitive impairment diagnosis neuropsychological assessment short intracortical inhibition intracortical facilitation fampridine walking disability TSPAN32 tetraspanins cellular immunity memory T cells tDCS neuroimaging positron emission tomography cerebral blood flow probiotics Streptococcus thermophilus ST285 MBP83–99 peptide mannan immune modulation agonist peptide gut microbiome gut–brain axis metagenomics disease-modifying treatments MS vaccine immunomodulation carriers B cell receptor delivery methods immunotherapy monoclonal antibodies T cell receptor tolerance diagnostic markers immunoglobulins kappa free light chains antigen-specific immunotherapies tolerogenic vaccines tolerance induction central nervous system myelin peptides myelin basic protei proteolipid protein myelin oligodendrocyte glycoprotein nanotechnology drug delivery nanosystems lipids polymers vaccines nanoparticles antigen-specific immunotherapy experimental autoimmune encephalomyelitis neurodegeneration chloroquine EAE dendritic cells microglia astrocytes oligodendrocytes conformational analysis peptides altered peptide ligands NMR spectroscopy NOE-constraints molecular dynamic trimolecular complex Multiple Sclerosis early-onset adult-onset Human Leucocyte Antigens immunogenetics clinical phenotype clinical outcome therapeutics antibody detection ELISA multivalency N-glucosylated peptide epitopes peptide conjugation MOG35-55 Graphite/SiO2 electrode voltammetry HPLC MS drugs thema EDItEUR::M Medicine and Nursing |
| topic_facet | multiple sclerosis inflammation oxidative biomarker sample size autoimmune encephalitis plasma exchange autoimmunity immunotherapeutics clinical outcomes major depression bupropion S-adenosylmethionine vitamin D3 yoga craniopharyngioma fractionated stereotactic radiation treatments sphenoid sinusitis cranial nerve-VI palsy autoimmune diseases immune thrombocytopenic purpura alemtuzumab antibodies against GluR3 peptide cognitive impairment diagnosis neuropsychological assessment short intracortical inhibition intracortical facilitation fampridine walking disability TSPAN32 tetraspanins cellular immunity memory T cells tDCS neuroimaging positron emission tomography cerebral blood flow probiotics Streptococcus thermophilus ST285 MBP83–99 peptide mannan immune modulation agonist peptide gut microbiome gut–brain axis metagenomics disease-modifying treatments MS vaccine immunomodulation carriers B cell receptor delivery methods immunotherapy monoclonal antibodies T cell receptor tolerance diagnostic markers immunoglobulins kappa free light chains antigen-specific immunotherapies tolerogenic vaccines tolerance induction central nervous system myelin peptides myelin basic protei proteolipid protein myelin oligodendrocyte glycoprotein nanotechnology drug delivery nanosystems lipids polymers vaccines nanoparticles antigen-specific immunotherapy experimental autoimmune encephalomyelitis neurodegeneration chloroquine EAE dendritic cells microglia astrocytes oligodendrocytes conformational analysis peptides altered peptide ligands NMR spectroscopy NOE-constraints molecular dynamic trimolecular complex Multiple Sclerosis early-onset adult-onset Human Leucocyte Antigens immunogenetics clinical phenotype clinical outcome therapeutics antibody detection ELISA multivalency N-glucosylated peptide epitopes peptide conjugation MOG35-55 Graphite/SiO2 electrode voltammetry HPLC MS drugs thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20210501_9783039439478_329 |